The death toll stands at 439,020 after the addition of 460 new fatalities After the subsiding of the second wave, India is now experiencing a new surge in COVID-19 cases. The rise in infections was notices when 41,965 samples tested

Johnson and Johnson made it clear in its statement that their experimental vaccines have failed to provide apt protection against HIV in the Sub-Saharan Africa region, to the young one who are most likely at a high risk of being

Expert committee suggestions will be implemented says Health Minister Sudhakar. Bengaluru: Looking at the possibility of COVID third wave, Karnataka Health Minister K Sudhakar on Monday said that the state is getting prepared to address the pandemic and will implement

Two months ago the medical device maker Philips had announced the recall of PhillipsContinuous positive airway pressure (CPAP), Bi-level positive airway pressure (Bi-Level PAP),and the mechanical ventilator devices. The state government of Tamil Nadu has asked thecompany to now either

It hasn’t been long since the country came out of the ghastly second wave of the Coronavirus infections. A huge chunk of our population got infected with the virus with many succumbing to death. While COVID-19 cases are still on

It is being claimed that taking both the doses of Covid-19 vaccine can still be the best way of protection against delta virus variant. This test result was first identified in India and now inthe United Kingdom as well. Further

A panel was chosen from the whole-exome and transcriptome data of over 1500 cancer patients, for 28 different types of cancer.  As per the company, most patients as a part of data sampling were on stage III and IV of

Visakhapatnam: The magnitude of the Covid-19 third wave will depend on adherence to appropriate behaviour, the extent of vaccination and aggressive surveillance, said Dr Randeep Guleria, noted pulmonologist and AIIMS Delhi director. Dr Guleria was bestowed Gitam Deemed-to-be University’s 41st

As per the analysts and healthcare investors, it is being predicted that drug-makers Pfizer Inc, Moderna Inc, BioNTech will reap billions of dollars from the Covid-19 booster shots, in the annual sales of flu vaccine markets that could rival $6